The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...
CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...
The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
SEOUL, South Korea, Nov. 19, 2025 /PRNewswire/ -- ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing ...
Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...
AZoLifeSciences on MSN
CRISPR Gets an Invisibility Cloak
CRISPR screens often mislead cancer research because bacterial Cas9 components trigger immune reactions in mice. ETH Zurich ...
IGIB and the Serum Institute of India aims to make sickle cell treatment accessible to India's tribal communities, where the ...
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback